Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-03-004373
Filing Date
2003-08-14
Accepted
2003-08-14 16:38:42
Documents
8
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c79086e10vq.txt 10-Q 167699
3 AMEND #1 TO PRE-NEGOTIATION AGREEMENT DTD 10/18/02 c79086exv10w1.txt EX-10.1 11795
4 AMEND #12 TO PRE-NEGOTIATION AGREEMENT DTD 6/30/03 c79086exv10w2.txt EX-10.2 39705
5 AMEND #13 TO PRE-NEGOTIATION AGREEMENT DTD 7/31/03 c79086exv10w3.txt EX-10.3 11964
6 SUBORDINATION AND STANDBY AGREEMENT c79086exv10w4.txt EX-10.4 19757
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c79086exv31w1.txt EX-31.1 3416
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER c79086exv31w2.txt EX-31.2 3428
9 906 CERTIFICATION OF CEO AND CFO c79086exv32w1.txt EX-32.1 2422
  Complete submission text file 0000950137-03-004373.txt   262751
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069 8472363800
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13976 | Film No.: 03848279
SIC: 2834 Pharmaceutical Preparations